We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
12.50 | 0.76% | 1,653.00 | 1,654.00 | 1,655.00 | 1,655.50 | 1,634.00 | 1,638.50 | 3,990,601 | 16:35:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.83 | 68.14B |
TIDMGSK
RNS Number : 4139F
GlaxoSmithKline PLC
20 February 2018
GlaxoSmithKline plc (the 'Company')
Shares sold to meet tax liabilities
Following the vesting of awards granted in 2015 under the GlaxoSmithKline 2009 Performance Share Plan on 15 February 2018 and as notified on 16 February 2018, the notifications that follow reflect changes in the interests of Persons Discharging Managerial Responsibilities ('PDMRs') in Ordinary Shares and in American Depositary Shares ('ADSs') of the Company arising from the sale of Ordinary Shares or ADSs to meet tax liabilities.
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') === ====================================================== a) Name Ms E Walmsley === ====================== ============================== b) Position/status Chief Executive Officer === ====================== ============================== c) Initial notification/ Initial notification amendment === ====================== ============================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ====================================================== a) Name GlaxoSmithKline plc === ====================== ============================== b) LEI 5493000HZTVUYLO1D793 === ====================== ============================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ====================================================== a) Description Ordinary shares of 25 pence of the financial each ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ============================== b) Nature of The sale of Ordinary Shares the transaction to meet tax liabilities for the vesting of awards granted in 2015 under the Company's 2009 Performance Share Plan. === ====================== ============================== c) Price(s) Price(s) Volume(s) and volume(s) ------------ ---------- GBP13.0726 65,247 ------------ ---------- === ====================== ============================== d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== ============================== e) Date of the 2018-02-16 transaction === ====================== ============================== f) Place of London Stock Exchange (XLON) the transaction === ====================== ============================== 1. Details of PDMR/person closely associated with them ('PCA') === ======================================================= a) Name Mr R G Connor === ====================== =============================== b) Position/status President, Global Manufacturing and Supply === ====================== =============================== c) Initial notification/ Initial notification amendment === ====================== =============================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ======================================================= a) Name GlaxoSmithKline plc === ====================== =============================== b) LEI 5493000HZTVUYLO1D793 === ====================== =============================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ======================================================= a) Description Ordinary shares of 25 pence of the financial each ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== =============================== b) Nature of The sale of Ordinary Shares the transaction to meet tax liabilities for the vesting of awards granted in 2015 under the Company's 2009 Performance Share Plan. === ====================== =============================== c) Price(s) Price(s) Volume(s) and volume(s) ------------ ---------- GBP13.0726 33,446 ------------ ---------- === ====================== =============================== d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== =============================== e) Date of the 2018-02-16 transaction === ====================== =============================== f) Place of London Stock Exchange (XLON) the transaction === ====================== =============================== 1. Details of PDMR/person closely associated with them ('PCA') === ======================================================= a) Name Mr N Hirons === ====================== =============================== b) Position/status SVP, Global Ethics & Compliance === ====================== =============================== c) Initial notification/ Initial notification amendment === ====================== =============================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ======================================================= a) Name GlaxoSmithKline plc === ====================== =============================== b) LEI 5493000HZTVUYLO1D793 === ====================== =============================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ======================================================= a) Description Ordinary shares of 25 pence of the financial each ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== =============================== b) Nature of The sale of Ordinary Shares the transaction to meet tax liabilities for the vesting of awards granted in 2015 under the Company's 2009 Performance Share Plan. === ====================== =============================== c) Price(s) Price(s) Volume(s) and volume(s) ------------ ---------- GBP13.0726 16,216 ------------ ---------- === ====================== =============================== d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== =============================== e) Date of the 2018-02-16 transaction === ====================== =============================== f) Place of London Stock Exchange (XLON) the transaction === ====================== =============================== 1. Details of PDMR/person closely associated with them ('PCA') === =========================================================== a) Name Mr B McNamara === ====================== =================================== b) Position/status CEO, Consumer Healthcare === ====================== =================================== c) Initial notification/ Initial notification amendment === ====================== =================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === =========================================================== a) Name GlaxoSmithKline plc === ====================== =================================== b) LEI 5493000HZTVUYLO1D793 === ====================== =================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === =========================================================== a) Description GlaxoSmithKline plc American of the financial Depositary Shares ('ADSs') instrument ISIN: US37733W1053 === ====================== =================================== b) Nature of The sale of ADSs to meet tax the transaction liabilities further to the vesting of awards granted in 2015 under the Company's 2009 Performance Share Plan. === ====================== =================================== c) Price(s) Price(s) Volume(s) and volume(s) --------- ----------
$37.4803 14,389 --------- ---------- === ====================== =================================== d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== =================================== e) Date of the 2018-02-16 transaction === ====================== =================================== f) Place of New York Stock Exchange (XNYS) the transaction === ====================== =================================== 1. Details of PDMR/person closely associated with them ('PCA') === ====================================================== a) Name Mr D S Redfern === ====================== ============================== b) Position/status Chief Strategy Officer === ====================== ============================== c) Initial notification/ Initial notification amendment === ====================== ============================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ====================================================== a) Name GlaxoSmithKline plc === ====================== ============================== b) LEI 5493000HZTVUYLO1D793 === ====================== ============================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ====================================================== a) Description Ordinary shares of 25 pence of the financial each ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ============================== b) Nature of The sale of Ordinary Shares the transaction to meet tax liabilities for the vesting of awards granted in 2015 under the Company's 2009 Performance Share Plan. === ====================== ============================== c) Price(s) Price(s) Volume(s) and volume(s) ------------ ---------- GBP13.0726 26,605 ------------ ---------- === ====================== ============================== d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== ============================== e) Date of the 2018-02-16 transaction === ====================== ============================== f) Place of London Stock Exchange (XLON) the transaction === ====================== ============================== 1. Details of PDMR/person closely associated with them ('PCA') === ====================================================== a) Name Ms C Thomas === ====================== ============================== b) Position/status SVP, Human Resources === ====================== ============================== c) Initial notification/ Initial notification amendment === ====================== ============================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ====================================================== a) Name GlaxoSmithKline plc === ====================== ============================== b) LEI 5493000HZTVUYLO1D793 === ====================== ============================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ====================================================== a) Description Ordinary shares of 25 pence of the financial each ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ============================== b) Nature of The sale of Ordinary Shares the transaction to meet tax liabilities for the vesting of awards granted in 2015 under the Company's 2009 Performance Share Plan. === ====================== ============================== c) Price(s) Price(s) Volume(s) and volume(s) ------------ ---------- GBP13.0726 35,473 ------------ ---------- === ====================== ============================== d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== ============================== e) Date of the 2018-02-16 transaction === ====================== ============================== f) Place of London Stock Exchange (XLON) the transaction === ====================== ============================== 1. Details of PDMR/person closely associated with them ('PCA') === ======================================================== a) Name Mr P C Thomson === ====================== ================================ b) Position/status SVP, Communications & Government Affairs === ====================== ================================ c) Initial notification/ Initial notification amendment === ====================== ================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ======================================================== a) Name GlaxoSmithKline plc === ====================== ================================ b) LEI 5493000HZTVUYLO1D793 === ====================== ================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ======================================================== a) Description Ordinary shares of 25 pence of the financial each ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ================================ b) Nature of The sale of Ordinary Shares the transaction to meet tax liabilities for the vesting of awards granted in 2015 under the Company's 2009 Performance Share Plan. === ====================== ================================ c) Price(s) Price(s) Volume(s) and volume(s) ------------ ---------- GBP13.0726 20,524 ------------ ---------- === ====================== ================================ d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== ================================ e) Date of the 2018-02-16 transaction === ====================== ================================ f) Place of London Stock Exchange (XLON) the transaction === ====================== ================================ 1. Details of PDMR/person closely associated with them ('PCA') === =========================================================== a) Name Mr D E Troy === ====================== =================================== b) Position/status SVP & General Counsel === ====================== =================================== c) Initial notification/ Initial notification amendment === ====================== =================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === =========================================================== a) Name GlaxoSmithKline plc === ====================== =================================== b) LEI 5493000HZTVUYLO1D793 === ====================== =================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === =========================================================== a) Description GlaxoSmithKline plc American of the financial Depositary Shares ('ADSs') instrument ISIN: US37733W1053 === ====================== =================================== b) Nature of The sale of ADSs to meet tax the transaction liabilities further to the vesting of awards granted in 2015 under the Company's 2009 Performance Share Plan. === ====================== =================================== c) Price(s) Price(s) Volume(s) and volume(s) --------- ----------
$37.4803 31,635 --------- ---------- === ====================== =================================== d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== =================================== e) Date of the 2018-02-16 transaction === ====================== =================================== f) Place of New York Stock Exchange (XNYS) the transaction === ====================== =================================== 1. Details of PDMR/person closely associated with them ('PCA') === ====================================================== a) Name Dr P J T Vallance === ====================== ============================== b) Position/status President, R&D === ====================== ============================== c) Initial notification/ Initial notification amendment === ====================== ============================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ====================================================== a) Name GlaxoSmithKline plc === ====================== ============================== b) LEI 5493000HZTVUYLO1D793 === ====================== ============================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ====================================================== a) Description Ordinary shares of 25 pence of the financial each ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ============================== b) Nature of The sale of Ordinary Shares the transaction to meet tax liabilities for the vesting of awards granted in 2015 under the Company's 2009 Performance Share Plan. === ====================== ============================== c) Price(s) Price(s) Volume(s) and volume(s) ------------ ---------- GBP13.0726 73,783 ------------ ---------- === ====================== ============================== d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== ============================== e) Date of the 2018-02-16 transaction === ====================== ============================== f) Place of London Stock Exchange (XLON) the transaction === ====================== ============================== 1. Details of PDMR/person closely associated with them ('PCA') === ====================================================== a) Name Mrs V A Whyte === ====================== ============================== b) Position/status Company Secretary === ====================== ============================== c) Initial notification/ Initial notification amendment === ====================== ============================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ====================================================== a) Name GlaxoSmithKline plc === ====================== ============================== b) LEI 5493000HZTVUYLO1D793 === ====================== ============================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ====================================================== a) Description Ordinary shares of 25 pence of the financial each ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ============================== b) Nature of The sale of Ordinary Shares the transaction to meet tax liabilities for the vesting of awards granted in 2015 under the Company's 2009 Performance Share Plan. === ====================== ============================== c) Price(s) Price(s) Volume(s) and volume(s) ------------ ---------- GBP13.0726 4,544 ------------ ---------- === ====================== ============================== d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== ============================== e) Date of the 2018-02-16 transaction === ====================== ============================== f) Place of London Stock Exchange (XLON) the transaction === ====================== ==============================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHXBLFLVLFFBBZ
(END) Dow Jones Newswires
February 20, 2018 08:17 ET (13:17 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions